
< Figure 1. Bird's-eye view of the KAIST Pavilion at CES 2026 >
KAIST announced on January 2nd that it will participate in the Consumer Electronics Show (CES 2026), held from January 6 to 9, 2026, at Eureka Park in the Venetian Expo, Las Vegas. KAIST will operate a dedicated 111㎡ "KAIST Pavilion" to showcase its innovative technologies to global corporations and investors.
A total of 12 startups will participate in the KAIST Pavilion at CES 2026. Notably, eight of these companies are built on core AI technologies, highlighting KAIST's artificial intelligence research capabilities and its achievements in technology commercialization.
The participating companies will unveil solutions targeting the global market across various high-tech sectors centered on AI, including robotics, bio-health, hardware devices, and content technology.
One of the standout participants is Hypergram, a faculty-led startup. Hypergram will introduce 'HG VNIR Pro,' the world’s first commercialized compressive hyperspectral imaging technology. This product is an end-to-end solution that integrates industrial-grade precision hardware with AI analysis software, capable of detecting minute chemical properties invisible to the human eye in real-time. During the exhibition, the company plans to demonstrate high-precision AI image analysis using its high-speed hyperspectral machine vision camera.

< Figure 2. Hypergram >
MOSS, a winner of the CES 2026 Innovation Award, will exhibit an AI-based, all-in-one mobile music production platform. This platform allows the general public and indie musicians to create high-quality music without a heavy financial burden. Visitors can experience the intuitiveness and innovation of the technology at an AI experience zone, where they can create music by linking the MOSS app with the dedicated hardware, 'MOSS Pocket Studio.'

< Figure 3. MOSS (Innovation Award Winning Product) >
BareulEye is developing a medical AI diagnostic solution that detects high-resolution changes in internal organ microstructures based on AI-powered quantitative ultrasound analysis technology. At CES 2026, they will unveil a 3D volume reconstruction technology that utilizes smart mirror-based self-ultrasound imaging.
Leveraging this technological prowess, BareulEye recently secured approximately $10 million (14 billion KRW) in a strategic Series A investment from a leading global healthcare company. Led by Professor Hyeon-min Bae, the Director of the KAIST Institute for Startup & Entrepreneurship and CEO of BareulEye, the company plans to accelerate joint technology development and overseas market expansion.

< Figure 4. BareulEye >
In addition to these, various KAIST startups leading innovation in AI, bio, and hardware devices will participate to solidify their foundations for entering the global market.
The KAIST Pavilion is designed with an open layout and large-scale LED displays to attract attention, featuring independent spaces for each company to facilitate in-depth technical presentations and investment consultations.
"Through CES 2026, we aim to imprint the AI-driven innovative technologies of KAIST startups on the global stage and establish a practical bridgehead for their international expansion," said Keon Jae Lee, Vice President of the KAIST Institute for Technology Value Creation.
KAIST extends its deepest condolences on the passing of the late Chairman Chang Sun Jung, founder of Jungheung Group. Chairman Jung made significant contributions to the development of Korea’s construction industry and regional economy, and was a visionary leader who deeply recognized and actively supported the importance of nurturing science and technology talent. In particular, through his generous contribution to the KAIST Development Fund, he left a meaningful legacy in fostering fu
2026-02-03< (From left) Dr. Ju-Gyeong Kang, Ph.D candidate TaeJun Seol, Professor Dae-Sik Lim > Metabolic diseases such as obesity, fatty liver, and insulin resistance are rapidly increasing worldwide, but fundamental methods to regulate the process of fat formation remain limited. In particular, once adipocytes (fat cells) are formed, they are difficult to reduce, making treatment challenging. Amidst this, a research team from our university has discovered the existence of a ‘switch&rsquo
2026-01-26<Jae-Chul Kim, Honorary Chairman of Dongwon Group> "In the era of AI, a new future lies within the sea of data. I ask that KAIST leaps forward to become the world's No. 1 AI research group." — Jae-Chul Kim, Honorary Chairman of Dongwon Group KAIST announced on January 16th that Honorary Chairman Jae-Chul Kim of Dongwon Group has pledged an additional 5.9 billion KRW in development funds to foster Artificial Intelligence (AI) talent and strengthen research infrastructure,
2026-01-16< (From left) Researcher Dongju Lim, Researcher Seokhwan Moon, Professor Jae Kyoung Kim (KAIST), Professor Jinsu Kim (POSTECH), Professor Byung-Kwan Cho (KAIST) > Why does cancer sometimes recur even after successful treatment, or why do some bacteria survive despite the use of powerful antibiotics? One of the key culprits identified is "Biological Noise"—random fluctuations occurring inside cells. Even when cells share the same genes, the amount of protein varies in each, creatin
2025-12-29<Photo of KAIST Students> KAIST announced on December 9th that it will accelerate the nurturing of world-class scientific talent and regional balanced development. This follows the government's recent announcement on 'Leaping to a Science and Technology Powerhouse, the Republic of Korea, Where People Dream of Becoming Science and Technology Professionals Again (Nov. 7),' which explicitly named the four major science and technology institutes, including KAIST, as AX (AI Transformation)
2025-12-09